Focus Stocks
Trading Idea: - Is Amgen close to Resistance?
Published on Monday, 10 September 2012 07:16 Written by TradersHuddle Wire
New York, September 10th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $85.28. The stock ended the trading session at just $83.96, which is near levels that make it difficult to buy or start a position.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
Amgen's stock range is defined by its calculated support defined at $75.70 and by the resistance level at $85.28; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Amgen. However, as the stock pulls back towards $75.70 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $85.28 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Approaching Support: Amgen
- Is Amgen Close to Support?
- Amgen Is Close to its 200 Day Moving Average
- Amgen Broke Support
- Trading the Setup In Amgen
- Approaching Support: Amgen
- Amgen Is Close to the 50 Day Moving Average
- Trading the Setup In Amgen
- NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
- Reference Points for Amgen
Related Partner Headlines
- Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCP - TheStreet.com
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) - TheStreet.com
- Amgen Inc (AMGN): Today's Featured Drugs Winner - TheStreet.com
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Did Not Meet Primary Endpoint - Benzinga
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- UPDATE: Oppenheimer Raises PT to $89 on Amgen - Benzinga
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Amgen - Benzinga
- Amgen's Third Quarter Earnings Report - Investopedia
- Analysts' Actions: CAT AMGN DNKN BTU COF - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,112.19 Trade time:4:52PM EDT Value change:▼206.04 (-1.35%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,628.93 Trade time:4:52PM EDT Value change:▼22.88 (-1.39%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,443.20 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
Tetragon Financial Group Limited (TFG) Monthly Update For May 2013 -
Raytheon's next generation of Enhanced Paveway™ II provides improved capability, performance -
Youku Tudou and Qualcomm Collaborate to Provide High Quality Video on its Mobile Platform -
Sikorsky, Boeing Form Joint Venture to Offer Saudi Rotorcraft Logistics and Training -
Celebrity Belt Manufacturer Belt-Manufactuer.comTargets Specialty Fashion Boutiques And Celebrity Brands For Submission Of Their 2013 Fall-Winter Lines -
The Portland Interior Designers of Garrison Hullinger Interior Design Selected by Pinnacle Management to Update Interiors of Luxury Condo Development, Waterfront Pearl -
eMazzanti Article Showcases Windows 8 Touch Technology -
Foundation Financial Group Will Take Steps for Crohn’s and Colitis








